Market Cap

Abcam plc Market Capitalization:

£3.21 Billion

GBP as of April 1, 2022

US$4.21 Billion

business Abcam plc Company Profile

Abcam plc Main Stock Listing

show_chart LSE: ABC

Market Capitalization History of Abcam plc

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $257.24 B
CSL Limited $89.69 B
Regeneron Pharmaceuticals, Inc. $74.91 B
Moderna, Inc. $70.81 B
Vertex Pharmaceuticals Incorporated $67.49 B
Sector: Healthcare
Company Market Cap (USD)
UnitedHealth Group $488.52 B
Johnson & Johnson $475.93 B
Roche $349.50 B
Pfizer $300.79 B
AbbVie $294.27 B

Yearly evolution of Abcam plc market cap

Date Market Cap YoY Change
Jan. 1, 2022 £3.17 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Abcam plc Categories

United Kingdom languages Healthcare languages Biotechnology
United Kingdom Healthcare United Kingdom Biotechnology

Stocks & Indices

Abcam plc has the following listings and related stock indices.


Stock: LSE: ABC

Stock: NASDAQ: ABCM

Stock: FSX: A8C1

Stock: FSX: A8C3

Stock: OTC: ABCZF

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.